Oncobix
Yongsin
About Oncobix
Oncobix is an operator of a drug development company that develops innovative treatments for rare and incurable diseases that are challenging to treat with modern medicine. For the well-being of humanity, the company invented a novel compound that can be represented by a chemical formula or a salt thereof, along with a pharmaceutical composition containing the compound, so that patients can enjoy innovative new drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $2.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2022)
- Website: oncobix.com
- Phone: +82-31-212-9104
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/oncobix-180360 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.